E2F7 and thyroid tumor: Pathological analysis revealed that four out of the five Rb+/−7−/− tumor lesions were medullary thyroid carcinomas, suggesting that loss of E2F7 aggravates the malignant progression of Rb-deficient thyroid tumors (Figure 3E,F).